Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Long Interspersed Nucleotide Elements | 13 | 2023 | 332 | 3.570 |
Why?
|
RNA-Directed DNA Polymerase | 4 | 2024 | 223 | 1.840 |
Why?
|
Ribonucleoproteins | 4 | 2018 | 359 | 1.370 |
Why?
|
Acyltransferases | 4 | 2015 | 306 | 1.240 |
Why?
|
Endonucleases | 2 | 2023 | 371 | 1.210 |
Why?
|
Ghrelin | 4 | 2015 | 251 | 0.950 |
Why?
|
Mutagenesis | 4 | 2024 | 1229 | 0.940 |
Why?
|
Open Reading Frames | 4 | 2016 | 812 | 0.920 |
Why?
|
Acute Lung Injury | 2 | 2018 | 378 | 0.910 |
Why?
|
Reverse Transcription | 1 | 2023 | 48 | 0.900 |
Why?
|
Enzyme Assays | 2 | 2015 | 103 | 0.840 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2024 | 481 | 0.740 |
Why?
|
DNA | 5 | 2024 | 7211 | 0.700 |
Why?
|
Chromosome Segregation | 1 | 2020 | 236 | 0.640 |
Why?
|
Granuloma, Plasma Cell | 1 | 2019 | 80 | 0.600 |
Why?
|
DNA Repair | 3 | 2024 | 2048 | 0.590 |
Why?
|
DNA Replication | 4 | 2024 | 1428 | 0.560 |
Why?
|
Macromolecular Substances | 2 | 2023 | 1435 | 0.540 |
Why?
|
Evolution, Molecular | 4 | 2024 | 1893 | 0.510 |
Why?
|
Carcinoma | 3 | 2023 | 2341 | 0.500 |
Why?
|
Pulmonary Alveoli | 1 | 2018 | 665 | 0.480 |
Why?
|
Autoantibodies | 3 | 2021 | 2126 | 0.480 |
Why?
|
Biotin | 1 | 2015 | 256 | 0.460 |
Why?
|
DNA Damage | 1 | 2024 | 2458 | 0.460 |
Why?
|
RNA | 4 | 2023 | 2726 | 0.450 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 551 | 0.450 |
Why?
|
Pulmonary Fibrosis | 1 | 2018 | 506 | 0.450 |
Why?
|
Genome | 3 | 2020 | 1747 | 0.440 |
Why?
|
RNA-Binding Protein EWS | 3 | 2019 | 211 | 0.430 |
Why?
|
Lupus Erythematosus, Systemic | 3 | 2021 | 2170 | 0.430 |
Why?
|
Multiprotein Complexes | 2 | 2016 | 1110 | 0.400 |
Why?
|
Mutation | 12 | 2024 | 30228 | 0.400 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2021 | 3666 | 0.400 |
Why?
|
Carcinoma, Pancreatic Ductal | 6 | 2021 | 1755 | 0.400 |
Why?
|
Lung Transplantation | 2 | 2018 | 1309 | 0.380 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2475 | 0.370 |
Why?
|
Colorectal Neoplasms | 8 | 2024 | 6971 | 0.370 |
Why?
|
Chromatography, Affinity | 3 | 2018 | 525 | 0.370 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2018 | 1482 | 0.340 |
Why?
|
Tumor Microenvironment | 6 | 2024 | 3939 | 0.330 |
Why?
|
Pancreatic Neoplasms | 7 | 2021 | 5443 | 0.330 |
Why?
|
Retroelements | 3 | 2023 | 162 | 0.330 |
Why?
|
Regeneration | 1 | 2018 | 1525 | 0.320 |
Why?
|
Sarcoma | 4 | 2021 | 1807 | 0.300 |
Why?
|
Barrett Esophagus | 2 | 2022 | 494 | 0.280 |
Why?
|
Enzyme Inhibitors | 3 | 2014 | 3722 | 0.280 |
Why?
|
Leucovorin | 5 | 2021 | 643 | 0.280 |
Why?
|
Genome, Human | 3 | 2015 | 4450 | 0.280 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4907 | 0.270 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 271 | 0.270 |
Why?
|
Liver Neoplasms | 5 | 2021 | 4365 | 0.270 |
Why?
|
Immunohistochemistry | 4 | 2022 | 11120 | 0.250 |
Why?
|
Mass Spectrometry | 4 | 2018 | 2201 | 0.250 |
Why?
|
Neoplasms | 8 | 2024 | 22385 | 0.250 |
Why?
|
Proteome | 2 | 2020 | 1881 | 0.240 |
Why?
|
Gene Expression | 3 | 2019 | 7598 | 0.240 |
Why?
|
Alkylation | 1 | 2024 | 84 | 0.230 |
Why?
|
Neoadjuvant Therapy | 6 | 2021 | 2909 | 0.230 |
Why?
|
SOXF Transcription Factors | 1 | 2024 | 31 | 0.230 |
Why?
|
HeLa Cells | 5 | 2020 | 3088 | 0.220 |
Why?
|
Fluorouracil | 5 | 2021 | 1655 | 0.220 |
Why?
|
DNA Adducts | 1 | 2024 | 95 | 0.220 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2024 | 58 | 0.210 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2024 | 199 | 0.210 |
Why?
|
Humans | 71 | 2024 | 768393 | 0.210 |
Why?
|
Interferons | 2 | 2023 | 716 | 0.210 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2024 | 366 | 0.200 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2022 | 108 | 0.190 |
Why?
|
Cell Line | 4 | 2024 | 15597 | 0.190 |
Why?
|
Homozygote | 6 | 2020 | 1779 | 0.180 |
Why?
|
Esophageal Neoplasms | 2 | 2022 | 1676 | 0.180 |
Why?
|
Germ Cells | 2 | 2022 | 643 | 0.180 |
Why?
|
Sister Chromatid Exchange | 1 | 2020 | 60 | 0.180 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2020 | 450 | 0.180 |
Why?
|
Immune Evasion | 1 | 2024 | 376 | 0.170 |
Why?
|
raf Kinases | 1 | 2020 | 117 | 0.170 |
Why?
|
HEK293 Cells | 6 | 2024 | 4291 | 0.170 |
Why?
|
Mucociliary Clearance | 1 | 2020 | 81 | 0.170 |
Why?
|
Adenocarcinoma | 4 | 2021 | 6406 | 0.170 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 433 | 0.170 |
Why?
|
Cryoelectron Microscopy | 1 | 2023 | 647 | 0.170 |
Why?
|
Neoplasm Invasiveness | 4 | 2022 | 3633 | 0.160 |
Why?
|
Gene Fusion | 2 | 2019 | 356 | 0.160 |
Why?
|
Transcription, Genetic | 3 | 2024 | 7599 | 0.160 |
Why?
|
Genetic Variation | 2 | 2020 | 6606 | 0.160 |
Why?
|
Common Variable Immunodeficiency | 1 | 2020 | 100 | 0.160 |
Why?
|
Crystallography, X-Ray | 1 | 2023 | 1952 | 0.160 |
Why?
|
Ultraviolet Rays | 1 | 2024 | 1100 | 0.160 |
Why?
|
Mice | 16 | 2024 | 82017 | 0.160 |
Why?
|
Lysosomes | 1 | 2024 | 939 | 0.160 |
Why?
|
RNA-Binding Protein FUS | 1 | 2019 | 77 | 0.160 |
Why?
|
Alleles | 4 | 2020 | 6892 | 0.150 |
Why?
|
Animals | 23 | 2024 | 169337 | 0.150 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2019 | 133 | 0.150 |
Why?
|
Heterozygote | 3 | 2014 | 2791 | 0.150 |
Why?
|
Gallbladder Neoplasms | 1 | 2020 | 191 | 0.150 |
Why?
|
Organometallic Compounds | 2 | 2020 | 648 | 0.150 |
Why?
|
Hepatitis | 1 | 2020 | 228 | 0.150 |
Why?
|
Amino Acids | 1 | 2024 | 1716 | 0.150 |
Why?
|
Selection, Genetic | 2 | 2020 | 877 | 0.150 |
Why?
|
Carcinoma, Small Cell | 1 | 2020 | 420 | 0.150 |
Why?
|
Bone Neoplasms | 2 | 2021 | 2565 | 0.150 |
Why?
|
Hypertension, Portal | 1 | 2020 | 230 | 0.150 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2018 | 88 | 0.140 |
Why?
|
Soft Tissue Neoplasms | 3 | 2021 | 1167 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11854 | 0.140 |
Why?
|
Autopsy | 1 | 2021 | 1013 | 0.140 |
Why?
|
Gene Rearrangement | 2 | 2019 | 1139 | 0.140 |
Why?
|
Structure-Activity Relationship | 2 | 2013 | 3055 | 0.140 |
Why?
|
Colonic Neoplasms | 2 | 2019 | 2544 | 0.140 |
Why?
|
NFATC Transcription Factors | 1 | 2019 | 393 | 0.140 |
Why?
|
Liposarcoma | 1 | 2019 | 289 | 0.130 |
Why?
|
Time | 1 | 2018 | 546 | 0.130 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 507 | 0.130 |
Why?
|
Cysts | 1 | 2021 | 685 | 0.130 |
Why?
|
Lymphatic Metastasis | 2 | 2020 | 2925 | 0.120 |
Why?
|
Baculoviridae | 1 | 2015 | 115 | 0.120 |
Why?
|
Genes, Neoplasm | 1 | 2017 | 370 | 0.120 |
Why?
|
DNA Polymerase I | 1 | 2015 | 44 | 0.120 |
Why?
|
Proteins | 2 | 2023 | 6006 | 0.120 |
Why?
|
Acylation | 2 | 2012 | 98 | 0.120 |
Why?
|
ras Proteins | 1 | 2020 | 1058 | 0.120 |
Why?
|
Amino Acid Sequence | 3 | 2018 | 13423 | 0.120 |
Why?
|
DNA Polymerase III | 1 | 2015 | 52 | 0.120 |
Why?
|
Protein Binding | 3 | 2016 | 9343 | 0.120 |
Why?
|
Phenelzine | 1 | 2014 | 28 | 0.120 |
Why?
|
Conserved Sequence | 2 | 2015 | 1163 | 0.120 |
Why?
|
Anophthalmos | 1 | 2014 | 23 | 0.120 |
Why?
|
Male | 31 | 2021 | 364902 | 0.120 |
Why?
|
Female | 30 | 2023 | 397089 | 0.110 |
Why?
|
Camptothecin | 1 | 2017 | 593 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9433 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2022 | 1188 | 0.110 |
Why?
|
Pancreas | 1 | 2020 | 1702 | 0.110 |
Why?
|
Deoxyribonuclease I | 1 | 2014 | 225 | 0.110 |
Why?
|
Adult | 21 | 2021 | 223640 | 0.110 |
Why?
|
Adenoma | 1 | 2024 | 2163 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1248 | 0.110 |
Why?
|
Signal Transduction | 5 | 2024 | 23631 | 0.110 |
Why?
|
Blood Vessels | 1 | 2019 | 1110 | 0.110 |
Why?
|
Poly(A)-Binding Protein I | 1 | 2012 | 15 | 0.100 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2013 | 287 | 0.100 |
Why?
|
RNA Helicases | 1 | 2013 | 144 | 0.100 |
Why?
|
Bacterial Infections | 1 | 2021 | 1397 | 0.100 |
Why?
|
Atlases as Topic | 1 | 2014 | 248 | 0.100 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4120 | 0.100 |
Why?
|
Codon, Nonsense | 1 | 2014 | 287 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2019 | 658 | 0.100 |
Why?
|
Receptors, Ghrelin | 1 | 2012 | 20 | 0.100 |
Why?
|
DNA-Binding Proteins | 3 | 2020 | 9614 | 0.100 |
Why?
|
Liver Diseases | 1 | 2021 | 1304 | 0.100 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1241 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2611 | 0.100 |
Why?
|
Catalysis | 1 | 2013 | 768 | 0.100 |
Why?
|
Lymph Nodes | 2 | 2020 | 3471 | 0.100 |
Why?
|
Molecular Sequence Annotation | 1 | 2014 | 525 | 0.100 |
Why?
|
Immunity, Innate | 1 | 2023 | 3078 | 0.090 |
Why?
|
Eye Abnormalities | 1 | 2014 | 243 | 0.090 |
Why?
|
Chickens | 1 | 2013 | 845 | 0.090 |
Why?
|
Histone Demethylases | 1 | 2014 | 322 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2024 | 3587 | 0.090 |
Why?
|
Neutrophils | 2 | 2021 | 3785 | 0.090 |
Why?
|
Eye Proteins | 1 | 2014 | 628 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2488 | 0.090 |
Why?
|
Protein Structure, Secondary | 1 | 2013 | 1216 | 0.090 |
Why?
|
Neoplasm Staging | 3 | 2020 | 11254 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3731 | 0.090 |
Why?
|
Middle Aged | 20 | 2021 | 223491 | 0.090 |
Why?
|
Repressor Proteins | 2 | 2019 | 2986 | 0.090 |
Why?
|
Intelligence | 1 | 2015 | 929 | 0.080 |
Why?
|
Cause of Death | 1 | 2020 | 3728 | 0.080 |
Why?
|
Aged | 17 | 2021 | 171562 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2020 | 1959 | 0.080 |
Why?
|
Sequence Alignment | 1 | 2013 | 2176 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2024 | 2911 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2022 | 2952 | 0.080 |
Why?
|
Peptides | 2 | 2012 | 4353 | 0.080 |
Why?
|
Prognosis | 8 | 2022 | 30022 | 0.080 |
Why?
|
Disease-Free Survival | 4 | 2020 | 6856 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3610 | 0.080 |
Why?
|
Chromatin | 2 | 2024 | 2968 | 0.080 |
Why?
|
Dogs | 1 | 2013 | 3846 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1667 | 0.080 |
Why?
|
Membrane Proteins | 3 | 2015 | 7880 | 0.070 |
Why?
|
Exons | 1 | 2013 | 2392 | 0.070 |
Why?
|
Genetic Heterogeneity | 2 | 2021 | 737 | 0.070 |
Why?
|
Organ Transplantation | 1 | 2017 | 1177 | 0.070 |
Why?
|
Models, Molecular | 2 | 2015 | 5404 | 0.070 |
Why?
|
Quantitative Trait Loci | 1 | 2015 | 2127 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3779 | 0.070 |
Why?
|
Cell Line, Tumor | 6 | 2020 | 17135 | 0.070 |
Why?
|
Down-Regulation | 1 | 2013 | 2940 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5800 | 0.070 |
Why?
|
Mice, Mutant Strains | 2 | 2020 | 1755 | 0.070 |
Why?
|
Binding Sites | 1 | 2015 | 6017 | 0.070 |
Why?
|
Enzyme Activation | 1 | 2012 | 3587 | 0.060 |
Why?
|
Genetic Vectors | 1 | 2015 | 3413 | 0.060 |
Why?
|
Forkhead Transcription Factors | 2 | 2022 | 1623 | 0.060 |
Why?
|
Hepatectomy | 2 | 2020 | 588 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4588 | 0.060 |
Why?
|
Phosphoproteins | 1 | 2014 | 2448 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2014 | 2593 | 0.060 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18362 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12778 | 0.060 |
Why?
|
Liver | 1 | 2020 | 7574 | 0.060 |
Why?
|
Rats, Inbred BN | 1 | 2004 | 231 | 0.060 |
Why?
|
Child | 7 | 2021 | 80891 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2024 | 6567 | 0.060 |
Why?
|
Trans-Activators | 1 | 2013 | 2856 | 0.060 |
Why?
|
Saccharomyces cerevisiae | 1 | 2015 | 2676 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2890 | 0.060 |
Why?
|
Macrophages | 1 | 2019 | 5796 | 0.060 |
Why?
|
Transcription Initiation Site | 2 | 2014 | 189 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2014 | 12805 | 0.050 |
Why?
|
Embryonal Carcinoma Stem Cells | 1 | 2023 | 20 | 0.050 |
Why?
|
Genomics | 2 | 2013 | 5916 | 0.050 |
Why?
|
Endoderm | 1 | 2024 | 165 | 0.050 |
Why?
|
Models, Biological | 2 | 2020 | 9493 | 0.050 |
Why?
|
Genotype | 2 | 2018 | 13042 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5801 | 0.050 |
Why?
|
Phenotype | 6 | 2020 | 16721 | 0.050 |
Why?
|
Prevalence | 1 | 2019 | 15872 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7463 | 0.050 |
Why?
|
Agrin | 1 | 2022 | 75 | 0.050 |
Why?
|
Ribonucleotides | 1 | 2022 | 114 | 0.050 |
Why?
|
Life Cycle Stages | 1 | 2022 | 161 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3543 | 0.050 |
Why?
|
Proteomics | 1 | 2015 | 3906 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2024 | 1992 | 0.050 |
Why?
|
Body Weight | 1 | 2012 | 4629 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17626 | 0.050 |
Why?
|
Lamivudine | 1 | 2022 | 367 | 0.040 |
Why?
|
Transcription Factors | 3 | 2015 | 12166 | 0.040 |
Why?
|
Disease Progression | 3 | 2024 | 13646 | 0.040 |
Why?
|
Weight Gain | 1 | 2010 | 2356 | 0.040 |
Why?
|
Genes, MHC Class I | 1 | 2021 | 236 | 0.040 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2020 | 110 | 0.040 |
Why?
|
Neoplasm Seeding | 1 | 2020 | 85 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2020 | 65379 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 199 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15455 | 0.040 |
Why?
|
Complement C1q | 1 | 2020 | 93 | 0.040 |
Why?
|
Turkey | 1 | 2020 | 256 | 0.040 |
Why?
|
Microscopy, Video | 1 | 2020 | 241 | 0.040 |
Why?
|
Heterocyclic Compounds | 1 | 2020 | 245 | 0.040 |
Why?
|
Asthma | 1 | 2018 | 6280 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 398 | 0.040 |
Why?
|
Glucose | 1 | 2010 | 4352 | 0.040 |
Why?
|
Molecular Probes | 1 | 2020 | 309 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2020 | 526 | 0.040 |
Why?
|
Biopsy | 2 | 2020 | 6808 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 60049 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 351 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2018 | 175 | 0.040 |
Why?
|
Antibodies, Antinuclear | 1 | 2020 | 343 | 0.040 |
Why?
|
Ethylnitrosourea | 1 | 2018 | 50 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2019 | 239 | 0.040 |
Why?
|
Germany | 1 | 2020 | 882 | 0.040 |
Why?
|
Epigenomics | 1 | 2024 | 959 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4921 | 0.040 |
Why?
|
Complement C3 | 1 | 2020 | 434 | 0.040 |
Why?
|
Organoids | 1 | 2024 | 746 | 0.040 |
Why?
|
Survival Analysis | 2 | 2020 | 10117 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2021 | 991 | 0.040 |
Why?
|
Pyroglyphidae | 1 | 2018 | 93 | 0.040 |
Why?
|
X-Ray Microtomography | 1 | 2020 | 457 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 784 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 7075 | 0.040 |
Why?
|
Blood Glucose | 1 | 2012 | 6430 | 0.030 |
Why?
|
Viral Proteins | 1 | 2024 | 1802 | 0.030 |
Why?
|
Introns | 2 | 2014 | 968 | 0.030 |
Why?
|
Adolescent | 6 | 2021 | 89184 | 0.030 |
Why?
|
Epithelial Cells | 2 | 2020 | 3695 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 362 | 0.030 |
Why?
|
Plasma Cells | 1 | 2020 | 599 | 0.030 |
Why?
|
Respiratory System | 1 | 2020 | 565 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13576 | 0.030 |
Why?
|
Pedigree | 2 | 2014 | 4544 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2020 | 1605 | 0.030 |
Why?
|
Lupus Nephritis | 1 | 2020 | 322 | 0.030 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2015 | 21 | 0.030 |
Why?
|
Point Mutation | 1 | 2021 | 1594 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2017 | 408 | 0.030 |
Why?
|
Scleroderma, Systemic | 1 | 2020 | 349 | 0.030 |
Why?
|
Pancreatectomy | 1 | 2020 | 824 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1421 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2024 | 3164 | 0.030 |
Why?
|
Scotland | 1 | 2015 | 142 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2019 | 572 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1003 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2019 | 930 | 0.030 |
Why?
|
Neurons | 1 | 2014 | 9513 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2020 | 81801 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39407 | 0.030 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2014 | 46 | 0.030 |
Why?
|
Cell Separation | 1 | 2020 | 1726 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8634 | 0.030 |
Why?
|
Corneal Opacity | 1 | 2014 | 52 | 0.030 |
Why?
|
Microphthalmos | 1 | 2014 | 58 | 0.030 |
Why?
|
Coloboma | 1 | 2014 | 60 | 0.030 |
Why?
|
Reference Values | 1 | 2021 | 4941 | 0.030 |
Why?
|
Monoamine Oxidase | 1 | 2014 | 180 | 0.030 |
Why?
|
Telomerase | 1 | 2019 | 752 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3345 | 0.030 |
Why?
|
Cohort Studies | 3 | 2021 | 41795 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1337 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2020 | 10478 | 0.030 |
Why?
|
Molecular Imaging | 1 | 2020 | 827 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2019 | 2524 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2077 | 0.030 |
Why?
|
Puromycin | 1 | 2012 | 41 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1105 | 0.030 |
Why?
|
Genes, Essential | 1 | 2014 | 185 | 0.030 |
Why?
|
Cystic Fibrosis | 1 | 2002 | 1285 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1962 | 0.030 |
Why?
|
Phylogeny | 1 | 2020 | 2843 | 0.030 |
Why?
|
Cell Survival | 2 | 2014 | 5792 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 2046 | 0.030 |
Why?
|
DNA Cleavage | 1 | 2012 | 56 | 0.020 |
Why?
|
Drug Combinations | 1 | 2018 | 2079 | 0.020 |
Why?
|
Peptide Chain Initiation, Translational | 1 | 2012 | 100 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22296 | 0.020 |
Why?
|
Collagen | 1 | 2020 | 2646 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3617 | 0.020 |
Why?
|
Polyadenylation | 1 | 2012 | 114 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2019 | 1614 | 0.020 |
Why?
|
Kinetics | 1 | 2018 | 6333 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2604 | 0.020 |
Why?
|
RNA Stability | 1 | 2012 | 321 | 0.020 |
Why?
|
Microcephaly | 1 | 2014 | 426 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4646 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3064 | 0.020 |
Why?
|
Gene Library | 1 | 2012 | 1061 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2020 | 5900 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2021 | 4570 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 1967 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1890 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 24318 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 1013 | 0.020 |
Why?
|
Hypersensitivity | 1 | 2018 | 1173 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4526 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2014 | 19022 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3617 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6541 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2014 | 1674 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9510 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8326 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3048 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8562 | 0.020 |
Why?
|
United States | 3 | 2020 | 73150 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2024 | 16028 | 0.020 |
Why?
|
Adenosine | 1 | 2012 | 817 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2010 | 1183 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2728 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20765 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12422 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 1958 | 0.020 |
Why?
|
Fetus | 1 | 2014 | 1883 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5037 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22355 | 0.020 |
Why?
|
Protein Conformation | 1 | 2014 | 3955 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2012 | 823 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14737 | 0.020 |
Why?
|
Ion Channels | 1 | 2010 | 1044 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8902 | 0.020 |
Why?
|
Drug Design | 1 | 2010 | 1046 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 1753 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12870 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 2012 | 2094 | 0.020 |
Why?
|
Polymers | 1 | 2012 | 1630 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2010 | 977 | 0.010 |
Why?
|
Databases, Factual | 1 | 2020 | 8075 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59686 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9562 | 0.010 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1350 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12092 | 0.010 |
Why?
|
Child, Preschool | 2 | 2019 | 42650 | 0.010 |
Why?
|
Base Composition | 1 | 2004 | 291 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2836 | 0.010 |
Why?
|
Immunotherapy | 1 | 2019 | 4738 | 0.010 |
Why?
|
Histones | 1 | 2014 | 2592 | 0.010 |
Why?
|
Rats | 2 | 2014 | 23835 | 0.010 |
Why?
|
Chromosomes, Mammalian | 1 | 2004 | 148 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2012 | 1883 | 0.010 |
Why?
|
Centromere | 1 | 2004 | 215 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3434 | 0.010 |
Why?
|
RNA Splice Sites | 1 | 2004 | 212 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36849 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18471 | 0.010 |
Why?
|
Gene Duplication | 1 | 2004 | 315 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 8199 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3458 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 18048 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15939 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8731 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11668 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21544 | 0.010 |
Why?
|
RNA, Untranslated | 1 | 2004 | 457 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2004 | 792 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2004 | 762 | 0.010 |
Why?
|
DNA Methylation | 1 | 2014 | 4421 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20224 | 0.010 |
Why?
|
Homeostasis | 1 | 2010 | 3349 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40272 | 0.010 |
Why?
|
CpG Islands | 1 | 2004 | 1209 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2012 | 4936 | 0.010 |
Why?
|
Lung | 1 | 2018 | 10089 | 0.010 |
Why?
|
Electrophysiology | 1 | 2002 | 1266 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 2004 | 871 | 0.010 |
Why?
|
Inflammation | 1 | 2018 | 10863 | 0.010 |
Why?
|
Telomere | 1 | 2004 | 943 | 0.010 |
Why?
|
Insulin | 1 | 2010 | 6607 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11918 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14481 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2002 | 1967 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4775 | 0.010 |
Why?
|